Management of renal cancer in 2007: Updates and recommendations;Prise en charge du cancer du rein en 2007: actualités et recommandations

Progres en Urologie

Volumn 18, Issue SUPPL.4, 2008, Pages

  Cornu, J N ^a   Roupret M ^a   Lang, H ^b   Long, J A ^c   Neuzillet, Y ^d   Patard, J J ^e   Piechaud T ^f   Correas J M ^g   de Fromont, M ^h   Escudier, B ⁱ   Mejean A ^g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f CLINIQUE SAINT AUGUSTIN   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h TIMONE HOSPITAL   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Good practice; Renal cell carcinoma; Sorafenib; Sunitinib; Surgery; Survival; Temsirolimus

Indexed keywords

ALGORITHM; ARTICLE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; PRACTICE GUIDELINE;

ALGORITHMS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 50849138906     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1166-7087(08)73667-4     Document Type: Article

References (34)

1. Letourneux H., Lindner V., Lang H., Massfelder T., Meyer N., Saussine C., et al. Reproductibilité du grade nucléaire de Fuhrman. Avantages d'un regroupement en deux grades. Prog Urol 16 (2006) 281-285
2. Lipworth L., Tarone R.E., and Mclaughlin J.K. The epidemiology of renal cell carcinoma. J Urol 176 (2006) 2353-2358
3. Mejean A. La chirurgie du cancer du rein au stade localement avancé. Prog Urol 17 (2007) 136-138
4. Neuzillet Y., Lechevallier E., and Coulange C. Cancer du rein et deuxième cancer : analyse critique de la littérature. Prog Urol 17 (2007) 35-40
5. Raynal G., and Bernhard J.C. Mortalité prématurée par cancer urologique : le rein en première ligne. Prog Urol 17 (2007) 260-261
6. Mckiernan J., Simmons R., Katz J., and Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59 (2002) 816-820
7. Méjean A. Jusqu'où pousser la néphrectomie partielle pour cancer du rein ?. Ann Urol 40 Suppl 3 (2006) S68-71
8. Bandi G., Wen C.C., Hedican S.P., Moon T.D., Lee Jr. F.T., and Nakada S.Y. Cryoablation of small renal masses: assessment of the outcome at one institution. BJU Int 100 (2007) 798-801
9. Simmons M.N., Kaouk J., Gill I.S., and Fergany A. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma. Urology 70 (2007) 43-46
10. Thiel D.D., and Winfield H.N. State-of-the-art surgical management of renal cell carcinoma. Expert Rev Anticancer Ther 7 (2007) 1285-1294
11. Zagoria R.J., Traver M.A., Werle D.M., Perini M., Hayasaka S., and Clark P.E. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189 (2007) 429-436
12. Mottet N. Place de la néphrectomie dans la prise en charge des cancers du rein métastatiques. Ann Urol 40 (2006) 273-279
13. Méjean A., Correas J.M., Escudier B., De Fromont M., Lang H., Long J.A., et al. Recommandations 2007 en onco-urologie:Tumeurs du rein. Prog Urol 17 (2007) 1101-1146
14. Luciani L.G. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 165 (2001) 1223
15. Flaherty K.T., Fuchs C.S., Colditz G.A., Stampfer M.J., Speizer F.E., Willet W.C., et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control 16 (2005) 1099-1106
16. Stewart J.H., Buccianti G., Agodoa L., Gellert R., Mccredie M.R., Lowenfels A.B., et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14 (2003) 197-207
17. Blute M.L., Leibovich B.C., Cheville J.C., Lohse C.M., and Zincke H. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172 (2004) 465-469
18. Lam J.S., Leppert J.T., Figlin R.A., and Belldegrun A.S. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 6 (2005) 7-18
19. Frank I., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
20. Patard J.J., Dorey F.J., Cindolo L., Ficarra V., De La Taille A., Tostain J., et al. Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol 172 (2004) 2167-2171
21. Patard J.J., Kim H.L., Lam J.S., Dorey F.J., Pantuck A.J., Zisman A., et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 22 (2004) 3316-3322
22. Belldegrun A., Tsui K.H., Dekernion J.B., and Smith R.B. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17 (1999) 2868-2875
23. Lau W.K., Blute M.L., Weaver A.L., Torres V.E., and Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 75 (2000) 1236-1242
24. Lee C.T., Katz J., Shi W., Thaler H.T., Reuter V.E., and Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 163 (2000) 730-736
25. Patard J.J., Shvarts O., Lam J.S., Pantuck A.J., Kim H.L., Ficarra V., et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 171 (2004) 2181-2185 quiz 2435
26. Uzzo R.G., and Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166 (2001) 6-18
27. Rule A.D., Larson T.S., Bergstralh E.J., Slevak J.M., Jacobsen S.J., and Cosio F.G. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004) 929-937
28. Chan D.Y., and Marshall F.F. Partial nephrectomy for centrally located tumors. Urology 54 (1999) 1088-1091 discussion 1091-1092
29. Timsit M.O., Bazin J.P., Thiounn N., Fontaine E., Chretien Y., Dufour B., et al. Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology 67 (2006) 923-926
30. Berdjis N., Hakenberg O.W., Leike S., Zastrow S., Manseck A., Oehlschlager S., et al. Comparison of transperitoneal versus retroperitoneal approach in laparoscopic radical nephrectomy for renal cell carcinoma: a single-center experience of 63 cases. Urol Int 77 (2006) 166-169
31. Permpongkosol S., Chan D.Y., Link R.E., Sroka M., Aallaf M., Varkarakis I., et al. Long-term survival analysis after laparoscopic radical nephrectomy. J Urol 174 (2005) 1222-1225
32. Campbell S.C., Krishnamurthi V., Chow G., Hale J., Myles J., and Novick A.C. Renal cryosurgery: experimental evaluation of treatment parameters. Urology 52 (1998) 29-33 discussion 33-34
33. Chosy S.G., Nakada S.Y., Lee Jr. F.T., and Warner T.F. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 159 (1998) 1370-1374
34. Gill I.S., Remer E.M., Hasan W.A., Strzempkowske B., Spaliviero M., Steinberg A.P., et al. Renal cryoablation : outcome at 3 years. J Urol 173 (2005) 1903-1907